HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Effect of positive surgical margins at radical prostatectomy on cancer-specific mortality in high/very high-risk prostate cancer patients with Gleason Grade Group 4-5.

AbstractBACKGROUND:
The effect of positive surgical margins (PSM) on cancer specific mortality (CSM) in high/very high-risk (HR/VHR) prostate cancer (PCa) with aggressive Gleason Grade Group (GGG) is unknown. We tested PSM effect on CSM in this setting, in addition to testing of radiotherapy (RT) benefit in PSM patients.
METHODS:
We relied on Surveillance, Epidemiology, and End Results database (2010-2015), focusing on HR/VHR patients with exclusive GGG 4-5 at radical prostatectomy (RP). Kaplan-Meier plots and multivariable Cox regression models tested the relationship between PSM and CSM. Moreover, the effect of RT on CSM was explored in PSM patients.
RESULTS:
Of 3383 HR/VHR patients, 15.1% (n = 511) exhibited PSM. Patients with PSM harbored higher rates of GGG 5 (60.1% vs. 50.9%, p < 0.001), pathologic tumor stage T3a (69.1% vs. 45.2%, p < 0.001) and lymph node involvement (14.1% vs. 9.4%, p < 0.001), relative to patients without PSM. PSM rates decreased over time (2010-2015) from 16.0% to 13.6%. Seven-year CSM-free survival rates were 91.6% versus 95.7% in patients with and without PSM, respectively. In multivariable Cox regression models, PSM was an independent predictor of CSM (hazard ratio = 1.6, p = 0.040) even after adjustment for age, prostate specific antigen, pathologic tumor stage and lymph node status. Finally, in PSM patients, RT delivery did not reduce CSM in either univariable or multivariable Cox regression models.
CONCLUSIONS:
In HR/VHR PCa patients with exclusive GGG 4-5, PSM at RP adversely affect survival. Moreover, RT has no protective effect on CSM. In consequence, lowest possible PSM rates are crucial in such patients.
AuthorsAndrea Panunzio, Gabriele Sorce, Benedikt Hoeh, Lukas Hohenhorst, Stefano Tappero, Nancy Nimer, Pawel Rajwa, Zhe Tian, Carlo Terrone, Felix K H Chun, Alberto Briganti, Fred Saad, Shahrokh F Shariat, Maria Angela Cerruto, Alessandro Antonelli, Pierre I Karakiewicz
JournalThe Prostate (Prostate) Vol. 83 Issue 3 Pg. 268-276 (02 2023) ISSN: 1097-0045 [Electronic] United States
PMID36336728 (Publication Type: Journal Article)
Copyright© 2022 Wiley Periodicals LLC.
Chemical References
  • Prostate-Specific Antigen
Topics
  • Male
  • Humans
  • Margins of Excision
  • Prostate (pathology)
  • Prostatic Neoplasms (pathology)
  • Prostatectomy (methods)
  • Prostate-Specific Antigen
  • Neoplasm Grading
  • Retrospective Studies

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: